Methodology and Baseline Data of a Comparative Exploratory Double-Blinded Randomized Study of Intravenous Iron on Fibroblast Growth Factor 23 and Phosphate in Chronic Kidney Disease

Methodology and Baseline Data of a Comparative Exploratory Double-Blinded Randomized Study of Intravenous Iron on Fibroblast Growth Factor 23 and Phosphate in Chronic Kidney Disease

Modern intravenous iron compounds (e.g., ferric carboxymaltose [FCM] and ferric derisomaltose [FDI]) are utilized in the treatment of iron deficiency anemia in non-dialysis-dependent chronic kidney disease (ND-CKD). Product-specific alterations in the metabolism of fibroblast growth factor 23 (FGF-2...

Full description

Bibliographic Details
Main Authors: Xenophon Kassianides, Sunil Bhandari
Format: Article
Language:English
Published: Karger Publishers 2023-05-01
Series:Kidney & Blood Pressure Research
Subjects:
chronic kidney disease
mineral bone disease
fibroblast growth factor 23
iron deficiency anemia
intravenous iron
phosphate
Online Access:https://beta.karger.com/Article/FullText/528313

Similar Items

Similar Items